CVI Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History

CVI Holdings’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-95,016	Closed	-$1M	–	86
2020 Q2	$1M	Buy	+95,016	New	+$720K	0.37%	36

Other funds holding ATNM

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CVI Holdings's ATNM Position: Q3 2020 in Review

CVI Holdings sold out of Actinium Pharmaceuticals (ATNM) in Q3 2020, closing a stake of 95,016 shares — an estimated $1M sold.

CVI Holdings first reported a position in ATNM in Q2 2020 and held it in 1 quarter. The position peaked at $1M in Q2 2020. 41 funds tracked by Wall St. Rank hold ATNM as of Q3 2020.

CVI Holdings reported no remaining Actinium Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 95,016 Actinium Pharmaceuticals shares in Q3 2020, an estimated $1M.
CVI Holdings first reported a position in Actinium Pharmaceuticals in Q2 2020 and held it in 1 quarter.
CVI Holdings's Actinium Pharmaceuticals position peaked at $1M in Q2 2020.
41 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.